Myelodysplastic syndrome in a patient with hereditary pyruvate kinase deficiency [2]

Hematology Journal

Volumn 5, Issue 1, 2004, Pages 91-92

  Ryan, Clodagh ^a   Percy, Melanie ^b   O'Brien, David ^a   Howard, Julie ^c   Smith, Edward Gordon ^d   McCann, Shaun ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b BELFAST CITY HOSPITAL   (United Kingdom)

^c OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; PYRUVATE KINASE; RECOMBINANT ERYTHROPOIETIN;

AGED; ANEMIA; BLOOD TRANSFUSION; CASE REPORT; CHROMOSOME 16; CHROMOSOME DELETION; DYSERYTHROPOIESIS; ENZYME DEFICIENCY; ERYTHROCYTE APLASIA; ERYTHROPOIESIS; FATIGUE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HEMATOLOGICAL PARAMETERS; HUMAN; LETTER; LIVER FUNCTION TEST; MALE; MYELODYSPLASTIC SYNDROME; PROGNOSIS; SIDEROBLASTIC ANEMIA; SYMPTOMATOLOGY;

AGED; ANEMIA; FAMILY HEALTH; HUMANS; MALE; MYELODYSPLASTIC SYNDROMES; PYRUVATE KINASE;

EID: 1342266600     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200352     Document Type: Letter

References (9)

1. Dacie J. Pyruvate kinase deficiency. In: Dacie J (ed). The Haemolytic Anaemias, Vol 1, 3rd edn. Churchill Livingstone: New York, 1995, pp 284-320.
2. Betts DR, Rohatiner AZ, Evans ML, Rassam SM, Lister TA, Gibbons B. Abnormalities of chromosome 16q in myeloid malignancy: 14 new cases and a review of the literature. Leukemia 1992; 6(12): 1250-1256.
3. Baronciani L, Beutler E. Molecular study of pyruvate kinase deficient patients with hereditary nonspherocytic haemolytic anaemia. J Clin Invest 1995; 95(4): 1702-1709.
4. Lezner C, Nurnberg P, Jacobasch G, Thiele BJ. Molecular analysis of 29 pyruvate kinase deficient patients from central Europe with hereditary haemolytic anaemia. Blood 1997; 89(5): 1793-1799.
5. Zanella A, Bianchi P, Fermo E, Iurlo A, Zappa M, Vercellati C et al. Molecular characterization of the PKLR gene in sixteen pyruvate kinase deficient patients. Br J Haematol 2001; 113(1): 43-48.
6. Boivin P, Galand C, Hakim J, Kahn A. Acquired erythroenzymopathies in blood disorders; study of 200 cases. Br J Haematol 1975; 31(4): 531-543.
7. Vives-Corrons JL, Florensa L, Mancunill J, Nomeleoleu B. Chronic myelomonocytic leukaemia associated with hereditary pyruvate kinase deficiency and multiple acquired erythrocyte abnormalities. Acta Haematol 1979; 61(3): 168-174.
8. Yoshida Y, Anzai N, Kawabata H. Apoptosis in myelodysplasia: a paradox or a paradigm. Leukemia Res 1995; 19: 887-891.
9. Yoshida Y, Mufti G. Apoptosis and its significance in MDS: controversies revisited. Leukemia Res 1999; 23: 777-785.